Commonly used treatments for chronic pain can do more harm than good and should not be used, says NICE in draft guidance
A number of commonly used drug treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE has said in its draft clinical guideline published today (3 August 2020) on the assessment and management of chronic pain in over 16s.
-
New combination treatment for patients with advanced kidney cancer
Adults with advanced renal cell carcinoma can now be offered avelumab with axitinib as a first line treatment option on the Cancer Drugs Fund (CDF), NICE has said in final draft guidance.
-
NICE publishes new COVID-19 rapid guideline on arranging planned care in hospitals and diagnostic services
NICE has today (27 July 2020) published a guideline on the arrangements the NHS should put in place for patients needing elective surgery and other planned treatments and procedures (including diagnostics and imaging) during the COVID-19 pandemic.
-
NICE signs agreement with Colombia’s Institute of Health Technology Assessment to forge closer working ties
Research and knowledge sharing key to collaborative working approach agreed the two agencies
